GeneDx set for worst day on record despite Q1 results beat
View all comments(0)
Genetic testing company GeneDx WGS.O shares slump 41.5% to $68.43 and set for biggest one-day fall on record
Co posts Q1 rev of $87.1 mln, down 8.6% from last quarter's $95.3 mln
Reports net loss of $6.5 mln, or 23 cents per share, in Q1
WGS, however, beats analysts' estimates for Q1 results and forecasts full-year revenue above estimates- LSEG data
Three out of 6 analysts rate stock as "buy" or higher, 3 "hold"; Median PT is $109.50
At last close, WGS was trading at over two-year high of $117.75
Including session's moves, WGS down ~11% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Like
Recommended Articles
Featured Tools
Top News
Why SanDisk Stock Could Soar to $4,000?

Is Micron the Next Nvidia? Why the 2026 "Memory Crunch" Makes MU Stock a Top AI Buy

'Big Short' Burry Doubles Down: Nvidia, Palantir Short Positions Double in Big Bet on AI Bubble Bursting

AI Chip Sector Adds Heavyweight Player, Nvidia Rival Cerebras Plans to List Next Week, Targeting Largest US IPO of the Year

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

Tradingkey







Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.